The Effectiveness of the Use of Oxygen Reserve Index in Preventing Hyperoxia in the Intensive Care Unit.

Sponsor
Tepecik Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05807815
Collaborator
(none)
60
1
2
24.4
2.5

Study Details

Study Description

Brief Summary

Oxygen therapy is the most common treatment modality for patients with hypoxemia in intensive care units, but target values for normoxemia are not clearly defined. Therefore, iatrogenic hyperoxemia is a very common situation. In intensive care units, FiO2 is usually adjusted according to hypoxia and hyperoxia is ignored in patients under mechanical ventilator support. Even though there are many side effects reported related to hyperoxemia and hyperoxemia is shown to be related to worse outcome than expected; clinicians still observe hyperoxemia frequently.

Continuous ORi monitoring can be used for detecting and preventing hyperoxia. The ability to perform FiO2 titration with ORi may be an appropriate monitoring management to prevent the harmful effects of hyperoxia. In this study, it was aimed to investigate the effectiveness of ORi-guided FiO2 titration in preventing hyperoxia in patients undergoing mechanical ventilation in the intensive care unit and to determine the incidence of hyperoxia.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Titration of fraction of inspired oxygen (FiO2) guided by ORI and oxygen saturation
N/A

Detailed Description

In intensive care units, FiO2 is usually adjusted according to hypoxia and hyperoxia is ignored in patients under mechanical ventilator support. Even though there are many side effects reported related to hyperoxemia and hyperoxemia is shown to be related to worse outcome than expected; clinicians still observe hyperoxemia frequently.

Oxygen reserve index (ORi™) (Masimo Corp., Irvine, USA) can guide clinicians in detection of hyperoxia. ORi is a parameter which can evaluate partial pressure of oxygen (PaO2) rating from 0 to 1. There are growing evidences in ORi that it might be helpful to reduce hyperoxia in general anesthesia. Continuous ORi monitoring can be used for detecting and preventing hyperoxia. The ability to perform FiO2 titration with ORi may be an appropriate monitoring management to prevent the harmful effects of hyperoxia.

In this study, it was aimed to investigate the effectiveness of ORi-guided FiO2 titration in preventing hyperoxia in patients undergoing mechanical ventilation in the intensive care unit and to determine the incidence of hyperoxia.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Determination of the Incidence of Hyperoxia and the Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia in Mechanically Ventilated Patients in the Intensive Care Unit.
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Mar 1, 2023
Actual Study Completion Date :
Mar 13, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

Patients with oxygen saturation > 97% will only be observed. ORi values will be recorded blindly from the clinician. Adjustments to be made in FiO2 will be determined by the intensive care doctor independently of the study, and only observation will be made in this group.

Active Comparator: ORi+SpO2 (oxygen saturation) group

Fraction of inspired oxygen (FiO2) is titrated guided by oxygen saturation in that range; %95<oxygen saturation≤%98

Procedure: Titration of fraction of inspired oxygen (FiO2) guided by ORI and oxygen saturation
FiO2 will be titrated by reducing 10% if Ori>0.01 and oxygen saturation ≥ 98% until Ori is 0.00. FiO2 will not be changed if Ori is 0.00 and %95<oxygen saturation≤%98 FiO2 will be increased by 10% if oxygen saturation <95 or PaO2<60 mmHg

Outcome Measures

Primary Outcome Measures

  1. Correlation of FiO2 and ORi value [Up to 24 weeks]

    Correlation of FiO2 value and ORi value. FiO2 adjusted until ORi reaches to zero and %95<oxygen saturation≤%98

Secondary Outcome Measures

  1. Fraction of inspired oxygen (FiO2) [Up to 48 hours]

    Fraction of inspired oxygen (FiO2) in every 4 hour intervals

  2. Mean arterial blood pressure (MAP) [Up to 48 hours]

    Measurement of mean arteria blood pressure (SBP)

  3. Heart rate (HR) [Up to 48 hours]

    Measurement of heart rate (HR)

  4. Positive end-expiratory pressure (PEEP) [Up to 48 hours]

    Measurement of PEEP

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients older than 18 years,

  • Patients whose oxygen saturation >97%

  • Patients that have invasive arterial monitorization

Exclusion Criteria:
  • Patients younger than 18

  • Patients that need to be treated with high doses of vasopressors,

  • Patients having peripheric hypoperfusion,

  • Hemodynamically unstable patients,

  • Patients with hemoglobinopathy,

  • Pregnancy,

  • Morbid obesity (bmi>40 kg/m2),

  • Patients with arrythmia that can result in hemodynamic instability, patients with acute coronary syndrome

  • Acute respiratory failure or ARDS.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tepecik Research and Training Hospital Izmir Konak Turkey 35110

Sponsors and Collaborators

  • Tepecik Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Aykut Saritas, associated professor, Tepecik Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT05807815
Other Study ID Numbers:
  • Health Sciences University
First Posted:
Apr 11, 2023
Last Update Posted:
Apr 11, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aykut Saritas, associated professor, Tepecik Training and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 11, 2023